`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Search results from the "OB_Rx" table for query on "203441."
`
`TEDUGLUTIDE RECOMBINANT
`POWDER;SUBCUTANEOUS
`GATTEX KIT
`NPS PHARMS INC
`5MG/VIAL
`N203441
`001
`Dec 21, 2012
`Yes
`RX
`
`Active Ingredient:
`Dosage Form;Route:
`Proprietary Name:
`Applicant:
`Strength:
`Application Number:
`Product Number:
`Approval Date:
`Reference Listed Drug
`RX/OTC/DISCN:
`TE Code:
`Patent and Exclusivity Info for this product:View
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data Monthly
`Generic Drug Product Information & Patent Information Daily
`Orange Book Data Updated Through July 2015
`Patent and Generic Drug Product Data Last Updated September 17, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading
`Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website
`Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1888INFOFDA (18884636332)
`Contact FDA
`
`
`
`
`
`
`
`
`
`
`
`
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=203441&TABLE1=OB_Rx
`
`1/2
`
`CFAD Exhibit 1039
`
`
`
`9/18/2015
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety
`Emergency Preparedness International Programs News & Events Training and Continuing Education
`Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/obdetail.cfm?Appl_No=203441&TABLE1=OB_Rx
`
`2/2
`
`CFAD Exhibit 1039
`
`
`
`9/21/2015
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Patent and Exclusivity Search Results from query on Appl No 203441 Product 001 in the OB_Rx list.
`
`Patent Data
`
`Appl No
`
`Prod No
`
`Patent No
`
`N203441
`N203441
`N203441
`N203441
`
`001
`001
`001
`001
`
`Exclusivity Data
`
`5789379
`7056886
`7847061
`9060992
`
`Patent
`Expiration
`Apr 14, 2016
`Sep 18, 2022
`Nov 1, 2025
`Nov 1, 2025
`
`Drug Substance
`Claim
`
`Drug Product
`Claim
`
`Y
`
`Y
`Y
`
`Patent Use
`Code
`U 1320
`U 1320
`U 1320
`U 1320
`
`Delist
`Requested
`
`Appl No
`
`Prod No
`
`Exclusivity Code
`
`N203441
`N203441
`
`001
`001
`
`ODE
`NCE
`
`Exclusivity Expiration
`Dec 21, 2019
`Dec 21, 2017
`
`Additional information:
`1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
`2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be
`flagged with respect to other claims which may apply.
`
`View a list of all patent use codes
`View a list of all exclusivity codes
`Return to Electronic Orange Book Home Page6
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data Monthly
`Generic Drug Product Information & Patent Information Daily
`Orange Book Data Updated Through August 2015
`Patent and Generic Drug Product Data Last Updated September 18, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1888INFOFDA (18884636332)
`Contact FDA
`
`
`
`
`
`
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`
`
`Links on this page:
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=203441&Product_No=001&table1=OB_Rx
`
`1/2
`
`CFAD Exhibit 1039
`
`
`
`9/21/2015
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5. ../default.cfm
`6. ../default.cfm
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=203441&Product_No=001&table1=OB_Rx
`
`2/2
`
`CFAD Exhibit 1039